Search Filters
Specialties
Knee
Specialties
Orthopaedics
Specialties
Shoulder
Clear All
Search
Specialties
Knee
Specialties
Orthopaedics
Specialties
Shoulder
672 results found in 11ms
MACI Recovery From Six Weeks to Two Years
avatar
Miss Sophie Harris
30/8/2026
MACI Recovery From Six Weeks to Two Years
Only a third of MACI patients return to their pre-operative sport level, despite most achieving pain-free function within six months and return to sport by 12–18 months. Kinesiophobia—fear of re-injury—emerges as a statistically significant independent predictor of this shortfall, distinct from tissue maturity.Only a third of MACI patients return to their pre-operative sport level, despite most achieving pain-free function within six months and return to sport by 12–18 months. Kinesiophobia—fear of re-injury—emerges as a statistically significant independent predictor of this shortfall, distinct from tissue maturity.
Questions to ask before a ChondroFiller injection
avatar
Miss Sophie Harris
24/8/2026
Questions to ask before a ChondroFiller injection
ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.
ChondroFiller repeat injections and long-term repair
avatar
Miss Sophie Harris
23/8/2026
ChondroFiller repeat injections and long-term repair
ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
When cartilage repair is the right choice
avatar
Miss Sophie Harris
20/8/2026
When cartilage repair is the right choice
Cartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.Cartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.
Physiotherapist or surgeon first for a meniscus tear
avatar
Miss Sophie Harris
20/8/2026
Physiotherapist or surgeon first for a meniscus tear
For most meniscus tears, physiotherapy is the evidence-supported first step; surgery is reserved for lockedknees, persistent instability, or severe acute injuries that fail to settle.For most meniscus tears, physiotherapy is the evidence-supported first step; surgery is reserved for locked knees, persistent instability, or severe acute injuries that fail to settle.
ChondroFiller Injection Evidence Patients Should Weigh
avatar
Miss Sophie Harris
15/8/2026
ChondroFiller Injection Evidence Patients Should Weigh
Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
ChondroFiller™ durability compared with Arthrosamid
avatar
Miss Sophie Harris
12/8/2026
ChondroFiller™ durability compared with Arthrosamid
ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
672 results found in 11ms